Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
15 hedge funds and large institutions have $11.4M invested in Checkpoint Therapeutics in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
474% more capital invested
Capital invested by funds: $1.99M → $11.4M (+$9.43M)
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
50% more funds holding
Funds holding: 10 → 15 (+5)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
1% more ownership
Funds ownership: 0.27% → 1.27% (+1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.52M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.66M |
| 3 |
Renaissance Technologies
New York
|
+$278K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$194K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$145K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BII
Bainco International Investors
Boston,
Massachusetts
|
-$264K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$39K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3.39K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| 5 |
Morgan Stanley
New York
|
-$489 |
CKPT Hedge Fund Activity: Q3 2018 in Review
15 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q3 2018, worth a combined $11.4M — up 474% from $1.99M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CKPT positions and 2 closed out — a net gain of 5 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, adding an estimated $5.52M. The largest seller was Bainco International Investors, cutting an estimated $264K.
- 15 institutional investors held Checkpoint Therapeutics (CKPT) as of Q3 2018, up from 10 in Q2 2018.
- Funds reported $11.4M of Checkpoint Therapeutics stock for Q3 2018, up 474% quarter-over-quarter.
- 7 funds opened new Checkpoint Therapeutics positions in Q3 2018 and 2 closed out, a net change of +5 holders.
- The largest Checkpoint Therapeutics buyer in Q3 2018 was BlackRock, an estimated $5.52M added.
- The largest Checkpoint Therapeutics seller in Q3 2018 was Bainco International Investors, an estimated $264K sold.
Based on aggregated 13F filings for Q3 2018.